Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

You should not be careless in any way. According to the report of the Centre for Disease Control and Prevention (CDC), about 50 per cent of diabetics suffer from diabetic neuropathy. There are many ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.

According to the company, its data replicate and expand upon the potential of ER-100 to improve retinal ganglion cell ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...

In addition to receiving my traditional cancer treatments, I also opt for integrative medicines, which have helped my mental ...

It isn't just me: up to 10% of American adults have diabetes. Most either don't know, or don't do anything about it.

AstraZeneca and Ionis are collaborating on the commercialisation of the drug following a December 2021 global agreement.

CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...

Foresee Pharmaceuticals Announces Preliminary Results from a Phase 1 Clinical Trial, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and ...

Arialys Therapeutics today announced the appointment of Sankalp "Sam" Gokhale, M.D., as Chief Medical Officer.